Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas
One of the more common malignancies orthopedic oncologists treat is soft-tissue sarcoma (STS). These tumors are a heterogeneous group that represent a small percentage of cancer diagnoses in the United States, with an incidence of 5 per 100 000 people per year.2,3 STS comprises numerous different histopathologic subtypes with varying degrees of aggressiveness. These tumors can vary from low to high grade and are identified most commonly in the extremities and less commonly in axial distribution. For many patients with STS, wide resection techniques offer curative treatment, often with adjuvant or neoadjuvant radiation treatment, depending on initial biopsy findings. With current advances in the surgical resection of STS, improved radiation techniques, and the increasing use of limb salvage surgery, many patients have had improved functional outcomes.